Discrepancies in readouts between Infinium MethylationEPIC v2.0 and v1.0 reflected in DNA methylation-based tools: implications and considerations for human population epigenetic studies
Beryl C. Zhuang,Marcia Smiti Jude,Chaini Konwar,Natan Yusupov,Calen Patrick Ryan,Hannah-Ruth Engelbrecht,Joanne Whitehead,Alexandra A. Halberstam,Julia L. MacIsaac,Kristy Dever,Toan Khanh Tran,Kim Korinek,Zachary Zimmer,Nanette R. Lee,Thomas W. McDade,Christopher W. Kuzawa,Kim M. Huffman,Daniel W. Belsky,Elisabeth B. Binder,Darina Czamara,Keegan Korthauer,Michael Steffen Kobor
DOI: https://doi.org/10.1101/2024.07.02.600461
2024-09-28
Abstract:Background: The recently launched DNA methylation profiling platform, Illumina MethylationEPIC BeadChip Infinium microarray v2.0 (EPICv2), is highly correlated with measurements obtained from its predecessor MethylationEPIC BeadChip Infinium microarray v1.0 (EPICv1). However, the concordance between the two versions in the context of DNA methylation-based tools, including cell type deconvolution algorithms, epigenetic clocks, and inflammation and lifestyle biomarkers has not yet been investigated. To address this, we profiled DNA methylation on both EPIC versions using matched venous blood samples from individuals spanning early to late adulthood across four cohorts. Findings: Within each cohort, samples primarily clustered by the EPIC version they were measured on. High concordance between EPIC versions at the array level, but variable concordance at the individual probe level was noted. Significant differences between versions in estimates from DNA methylation-based tools were observed, irrespective of the normalization method, with some nuanced differences across cohorts and tools. Adjusting for EPIC version or calculating estimates separately for each version largely mitigated these version-specific discordances. Conclusions: Our work illustrates the importance of accounting for EPIC version differences in research scenarios, especially in meta-analyses and longitudinal studies, when samples profiled across different versions are harmonized. Alongside DNA methylation-based tools, our observations also have implications in interpretation of epigenome-wide association studies (EWAS) findings, when results obtained from one version are compared to another, particularly for probes that are poorly concordant between versions.
Genomics